Document is current

Any future updates will be listed below

Two-year administration of sodium-glucose co-transporter 2 inhibitor brought about marked reduction of body fat independent of skeletal muscle amount or glycemic improvement in Japanese patients with type 2 diabetes

Crossref DOI link: https://doi.org/10.1007/s13340-021-00512-7

Published Online: 2021-05-21

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark